This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2shp
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /> <applet load="2shp" size="450" color="white" frame="true" align="right" spinBox="true" caption="2shp, resolution 2.00Å" /> '''TYROSINE PHOSPHATAS...)
Next diff →
Revision as of 21:31, 12 November 2007
|
TYROSINE PHOSPHATASE SHP-2
Contents |
Overview
The structure of the SHP-2 tyrosine phosphatase, determined at 2.0, angstroms resolution, shows how its catalytic activity is regulated by its, two SH2 domains. In the absence of a tyrosine-phosphorylated binding, partner, the N-terminal SH2 domain binds the phosphatase domain and, directly blocks its active site. This interaction alters the structure of, the N-SH2 domain, disrupting its phosphopeptide-binding cleft. Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its, phosphatase recognition surface. Thus, the N-SH2 domain is a, conformational switch; it either binds and inhibits the phosphatase, or it, binds phosphoproteins and activates the enzyme. Recognition of, bisphosphorylated ligands by the tandem SH2 domains is an integral element, of this switch; the C-terminal SH2 domain contributes binding energy and, specificity, but it does not have a direct role in activation.
Disease
Known diseases associated with this structure: Leopard syndrome OMIM:[176876], Leukemia, juvenile myelomonocytic OMIM:[176876], Noonan syndrome 1 OMIM:[176876]
About this Structure
2SHP is a Single protein structure of sequence from Homo sapiens with CAT as ligand. Active as Protein-tyrosine-phosphatase, with EC number 3.1.3.48 Full crystallographic information is available from OCA.
Reference
Crystal structure of the tyrosine phosphatase SHP-2., Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE, Cell. 1998 Feb 20;92(4):441-50. PMID:9491886
Page seeded by OCA on Mon Nov 12 23:38:08 2007
